{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:32:47Z","timestamp":1791891167637,"version":"4.3.4"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,10,5]],"date-time":"2010-10-05T00:00:00Z","timestamp":1286236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s12016-010-8213-3","type":"journal-article","created":{"date-parts":[[2010,10,4]],"date-time":"2010-10-04T02:03:01Z","timestamp":1286157781000},"page":"121-130","source":"Crossref","is-referenced-by-count":103,"title":["Guillain\u2013Barr\u00e9 Syndrome\u2014A Classical Autoimmune Disease Triggered by Infection or Vaccination"],"prefix":"10.1007","volume":"42","author":[{"given":"Eitan","family":"Israeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Agmon-Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miri","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joab","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,10,5]]},"reference":[{"key":"8213_CR1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jocn.2008.08.033","volume":"16","author":"S Vucic","year":"2009","unstructured":"Vucic S, Kiernan MC, Cornblath DR (2009) Guillain\u2013Barre syndrome: an update. J Clin Neurosci 16:733\u2013741","journal-title":"J Clin Neurosci"},{"key":"8213_CR2","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","volume":"366","author":"RA Hughes","year":"2005","unstructured":"Hughes RA, Cornblath DR (2005) Guillain\u2013Barre syndrome. Lancet 366:1653\u20131666","journal-title":"Lancet"},{"key":"8213_CR3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0140-6736(91)90606-P","volume":"338","author":"GM McKhann","year":"1991","unstructured":"McKhann GM, Cornblath DR, Ho T, Li CY, Bai AY, Wu HS et al (1991) Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China. Lancet 338:593\u2013597","journal-title":"Lancet"},{"issue":"Pt 3","key":"8213_CR4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/brain\/118.3.597","volume":"118","author":"TW Ho","year":"1995","unstructured":"Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW et al (1995) Guillain\u2013Barre syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118(Pt 3):597\u2013605","journal-title":"Brain"},{"issue":"Pt 3","key":"8213_CR5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/118.3.577","volume":"118","author":"JW Griffin","year":"1995","unstructured":"Griffin JW, Li CY, Ho TW, Xue P, Macko C, Gao CY et al (1995) Guillain\u2013Barre syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 118(Pt 3):577\u2013595","journal-title":"Brain"},{"key":"8213_CR6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0167-5699(93)90244-F","volume":"14","author":"NR Rose","year":"1993","unstructured":"Rose NR, Bona C (1993) Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 14:426\u2013430","journal-title":"Immunol Today"},{"key":"8213_CR7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000237258","volume":"109","author":"Y Shoenfeld","year":"1996","unstructured":"Shoenfeld Y, George J, Peter JB (1996) Guillain\u2013Barre as an autoimmune disease. Int Arch Allergy Immunol 109:318\u2013326","journal-title":"Int Arch Allergy Immunol"},{"key":"8213_CR8","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-60327-285-8","volume-title":"Diagnostic criteria in autoimmune diseases","author":"Y Shoenfeld","year":"2008","unstructured":"Shoenfeld Y, Cervera R, Gershwin ME (2008) Diagnostic criteria in autoimmune diseases. Humana, Totowa"},{"key":"8213_CR9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1085-9489.2005.0010202.x","volume":"10","author":"HJ Willison","year":"2005","unstructured":"Willison HJ (2005) The immunobiology of Guillain\u2013Barre syndromes. J Peripher Nerv Syst 10:94\u2013112","journal-title":"J Peripher Nerv Syst"},{"key":"8213_CR10","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1001\/archneur.1991.00530220102027","volume":"48","author":"R Gruenewald","year":"1991","unstructured":"Gruenewald R, Ropper AH, Lior H, Chan J, Lee R, Molinaro VS (1991) Serologic evidence of Campylobacter jejuni\/coli enteritis in patients with Guillain\u2013Barre syndrome. Arch Neurol 48:1080\u20131082","journal-title":"Arch Neurol"},{"key":"8213_CR11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/jnnp.27.5.395","volume":"27","author":"SC Melnick","year":"1964","unstructured":"Melnick SC, Flewett TH (1964) Role of infection in the Guillain\u2013Barre syndrome. J Neurol Neurosurg Psychiatry 27:395\u2013407","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8213_CR12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/oxfordjournals.aje.a009369","volume":"147","author":"E Kinnunen","year":"1998","unstructured":"Kinnunen E, Junttila O, Haukka J, Hovi T (1998) Nationwide oral poliovirus vaccination campaign and the incidence of Guillain\u2013Barre syndrome. Am J Epidemiol 147:69\u201373","journal-title":"Am J Epidemiol"},{"key":"8213_CR13","first-page":"105","volume":"16","author":"GF Liu","year":"2003","unstructured":"Liu GF, Wu ZL, Wu HS, Wang QY, Zhao-Ri GT, Wang CY et al (2003) A case\u2013control study on children with Guillain\u2013Barre syndrome in North China. Biomed Environ Sci 16:105\u2013111","journal-title":"Biomed Environ Sci"},{"key":"8213_CR14","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00431-006-0140-1","volume":"165","author":"J Schessl","year":"2006","unstructured":"Schessl J, Luther B, Kirschner J, Mauff G, Korinthenberg R (2006) Infections and vaccinations preceding childhood Guillain\u2013Barre syndrome: a prospective study. Eur J Pediatr 165:605\u2013612","journal-title":"Eur J Pediatr"},{"key":"8213_CR15","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/aje\/kwn310","volume":"169","author":"J Stowe","year":"2009","unstructured":"Stowe J, Andrews N, Wise L, Miller E (2009) Investigation of the temporal association of Guillain\u2013Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom general practice research database. Am J Epidemiol 169:382\u2013388","journal-title":"Am J Epidemiol"},{"key":"8213_CR16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3201\/eid1503.071482","volume":"15","author":"G Lebrun","year":"2009","unstructured":"Lebrun G, Chadda K, Reboux AH, Martinet O, Gauzere BA (2009) Guillain\u2013Barre syndrome after chikungunya infection. Emerg Infect Dis 15:495\u2013496","journal-title":"Emerg Infect Dis"},{"key":"8213_CR17","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3748\/wjg.15.1645","volume":"15","author":"JP Loly","year":"2009","unstructured":"Loly JP, Rikir E, Seivert M, Legros E, Defrance P, Belaiche J et al (2009) Guillain\u2013Barre syndrome following hepatitis E. World J Gastroenterol 15:1645\u20131647","journal-title":"World J Gastroenterol"},{"key":"8213_CR18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.it.2009.05.005","volume":"30","author":"S Kivity","year":"2009","unstructured":"Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y (2009) Infections and autoimmunity\u2014friends or foes? Trends Immunol 30:409\u2013414","journal-title":"Trends Immunol"},{"key":"8213_CR19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0022-510X(96)05318-X","volume":"147","author":"R Bakshi","year":"1997","unstructured":"Bakshi R, Graves MC (1997) Guillain\u2013Barre syndrome after combined tetanus-diphtheria toxoid vaccination. J Neurol Sci 147:201\u2013202","journal-title":"J Neurol Sci"},{"key":"8213_CR20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/BF01954093","volume":"152","author":"A Gervaix","year":"1993","unstructured":"Gervaix A, Caflisch M, Suter S, Haenggeli CA (1993) Guillain\u2013Barre syndrome following immunisation with Haemophilus influenzae type b conjugate vaccine. Eur J Pediatr 152:613\u2013614","journal-title":"Eur J Pediatr"},{"key":"8213_CR21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0022-3476(05)81876-1","volume":"118","author":"TP Gross","year":"1991","unstructured":"Gross TP, Hayes SW (1991) Haemophilus conjugate vaccine and Guillain\u2013Barre syndrome. J Pediatr 118:161","journal-title":"J Pediatr"},{"key":"8213_CR22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/archneur.1983.04050010076025","volume":"40","author":"PL Holliday","year":"1983","unstructured":"Holliday PL, Bauer RB (1983) Polyradiculoneuritis secondary to immunization with tetanus and diphtheria toxoids. Arch Neurol 40:56\u201357","journal-title":"Arch Neurol"},{"key":"8213_CR23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(94)90917-2","volume":"343","author":"K Morris","year":"1994","unstructured":"Morris K, Rylance G (1994) Guillain\u2013Barre syndrome after measles, mumps, and rubella vaccine. Lancet 343:60","journal-title":"Lancet"},{"key":"8213_CR24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","volume":"110","author":"LB Schonberger","year":"1979","unstructured":"Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, Keenlyside RA, Ziegler DW, Retailliau HF et al (1979) Guillain\u2013Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977. Am J Epidemiol 110:105\u2013123","journal-title":"Am J Epidemiol"},{"key":"8213_CR25","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/oxfordjournals.aje.a113810","volume":"119","author":"JG Breman","year":"1984","unstructured":"Breman JG, Hayner NS (1984) Guillain\u2013Barre syndrome and its relationship to swine influenza vaccination in Michigan, 1976\u20131977. Am J Epidemiol 119:880\u2013889","journal-title":"Am J Epidemiol"},{"key":"8213_CR26","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.52.8.1546","volume":"52","author":"GM Fenichel","year":"1999","unstructured":"Fenichel GM (1999) Assessment: neurologic risk of immunization: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 52:1546\u20131552","journal-title":"Neurology"},{"key":"8213_CR27","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/jnnp.51.5.613","volume":"51","author":"JB Winer","year":"1988","unstructured":"Winer JB, Hughes RA, Anderson MJ, Jones DM, Kangro H, Watkins RP (1988) A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry 51:613\u2013618","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8213_CR28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(94)91614-4","volume":"343","author":"J Rees","year":"1994","unstructured":"Rees J, Hughes R (1994) Guillain\u2013Barre syndrome after measles, mumps, and rubella vaccine. Lancet 343:733","journal-title":"Lancet"},{"key":"8213_CR29","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/bmj.312.7044.1475d","volume":"312","author":"R Hughes","year":"1996","unstructured":"Hughes R, Rees J, Smeeton N, Winer J (1996) Vaccines and Guillain\u2013Barre syndrome. Bmj 312:1475\u20131476","journal-title":"Bmj"},{"key":"8213_CR30","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199812173392501","volume":"339","author":"T Lasky","year":"1998","unstructured":"Lasky T, Terracciano GJ, Magder L, Koski CL, Ballesteros M, Nash D et al (1998) The Guillain\u2013Barre syndrome and the 1992\u20131993 and 1993\u20131994 influenza vaccines. N Engl J Med 339:1797\u20131802","journal-title":"N Engl J Med"},{"key":"8213_CR31","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/(SICI)1097-4598(199607)19:7<836::AID-MUS4>3.0.CO;2-A","volume":"19","author":"RA Hughes","year":"1996","unstructured":"Hughes RA, Choudhary PP, Osborn M, Rees JH, Sanders EA (1996) Immunization and risk of relapse of Guillain\u2013Barre syndrome or chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 19:1230\u20131231","journal-title":"Muscle Nerve"},{"key":"8213_CR32","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJM199812173392509","volume":"339","author":"AH Ropper","year":"1998","unstructured":"Ropper AH, Victor M (1998) Influenza vaccination and the Guillain\u2013Barre syndrome. N Engl J Med 339:1845\u20131846","journal-title":"N Engl J Med"},{"key":"8213_CR33","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1212\/WNL.28.7.725","volume":"28","author":"M Seyal","year":"1978","unstructured":"Seyal M, Ziegler DK, Couch JR (1978) Recurrent Guillain\u2013Barre syndrome following influenza vaccine. Neurology 28:725\u2013726","journal-title":"Neurology"},{"key":"8213_CR34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0022-510X(78)90232-0","volume":"37","author":"JD Pollard","year":"1978","unstructured":"Pollard JD, Selby G (1978) Relapsing neuropathy due to tetanus toxoid. Report of a case. J Neurol Sci 37:113\u2013125","journal-title":"J Neurol Sci"},{"key":"8213_CR35","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1212\/WNL.55.3.452","volume":"55","author":"EF Wijdicks","year":"2000","unstructured":"Wijdicks EF, Fletcher DD, Lawn ND (2000) Influenza vaccine and the risk of relapse of Guillain\u2013Barre syndrome. Neurology 55:452\u2013453","journal-title":"Neurology"},{"key":"8213_CR36","first-page":"1204","volume":"295","author":"LW Myers","year":"1976","unstructured":"Myers LW, Ellison GW, Lucia M, Novom S (1976) Swine-influenza vaccination in multiple sclerosis. N Engl J Med 295:1204","journal-title":"N Engl J Med"},{"key":"8213_CR37","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1212\/WNL.48.2.312","volume":"48","author":"AE Miller","year":"1997","unstructured":"Miller AE, Morgante LA, Buchwald LY, Nutile SM, Coyle PK, Krupp LB et al (1997) A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology 48:312\u2013314","journal-title":"Neurology"},{"key":"8213_CR38","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0896-6273(00)80323-2","volume":"18","author":"JL Salzer","year":"1997","unstructured":"Salzer JL (1997) Clustering sodium channels at the node of Ranvier: close encounters of the axon-glia kind. Neuron 18:843\u2013846","journal-title":"Neuron"},{"key":"8213_CR39","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1086\/589624","volume":"198","author":"I Nachamkin","year":"2008","unstructured":"Nachamkin I, Shadomy SV, Moran AP, Cox N, Fitzgerald C, Ung H et al (2008) Anti-ganglioside antibody induction by swine (A\/NJ\/1976\/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain\u2013Barre syndrome. J Infect Dis 198:226\u2013233","journal-title":"J Infect Dis"},{"key":"8213_CR40","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0961203309346653","volume":"18","author":"N Agmon-Levin","year":"2009","unstructured":"Agmon-Levin N, Blank M, Paz Z, Shoenfeld Y (2009) Molecular mimicry in systemic lupus erythematosus. Lupus 18:1181\u20131185","journal-title":"Lupus"},{"key":"8213_CR41","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.0402391101","volume":"101","author":"N Yuki","year":"2004","unstructured":"Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K et al (2004) Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain\u2013Barre syndrome. Proc Natl Acad Sci USA 101:11404\u201311409","journal-title":"Proc Natl Acad Sci USA"},{"key":"8213_CR42","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.bbagen.2007.10.001","volume":"1780","author":"S Kusunoki","year":"2008","unstructured":"Kusunoki S, Kaida K, Ueda M (2008) Antibodies against gangliosides and ganglioside complexes in Guillain\u2013Barre syndrome: new aspects of research. Biochim Biophys Acta 1780:441\u2013444","journal-title":"Biochim Biophys Acta"},{"key":"8213_CR43","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2174\/187152706777950765","volume":"5","author":"T Komagamine","year":"2006","unstructured":"Komagamine T, Yuki N (2006) Ganglioside mimicry as a cause of Guillain\u2013Barre syndrome. CNS Neurol Disord Drug Targets 5:391\u2013400","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"8213_CR44","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1086\/499969","volume":"193","author":"M Koga","year":"2006","unstructured":"Koga M, Gilbert M, Takahashi M, Li J, Koike S, Hirata K et al (2006) Comprehensive analysis of bacterial risk factors for the development of Guillain\u2013Barre syndrome after Campylobacter jejuni enteritis. J Infect Dis 193:547\u2013555","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"8213_CR45","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1471-4159.2007.04707.x","volume":"103","author":"N Yuki","year":"2007","unstructured":"Yuki N (2007) Campylobacter sialyltransferase gene polymorphism directs clinical features of Guillain\u2013Barre syndrome. J Neurochem 103(Suppl 1):150\u2013158","journal-title":"J Neurochem"},{"key":"8213_CR46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12016-009-8155-9","volume":"38","author":"SKU Kivity","year":"2009","unstructured":"Kivity SKU, Daniel N, Nussinovitch U, Papageorgiou N, Shoenfeld Y (2009) Evidence for the use of intravenous immunoglobulins\u2014a review of the literature. Clin Rev Allergy Immunol 38:201\u2013269","journal-title":"Clin Rev Allergy Immunol"},{"key":"8213_CR47","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/jnr.490120212","volume":"12","author":"AL Ganser","year":"1984","unstructured":"Ganser AL, Kirschner DA (1984) Differential expression of gangliosides on the surfaces of myelinated nerve fibers. J Neurosci Res 12:245\u2013255","journal-title":"J Neurosci Res"},{"key":"8213_CR48","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/brain\/awn005","volume":"131","author":"E Shavit","year":"2008","unstructured":"Shavit E, Beilin O, Korczyn AD, Sylantiev C, Aronovich R, Drory VE et al (2008) Thrombin receptor PAR-1 on myelin at the node of Ranvier: a new anatomy and physiology of conduction block. Brain 131:1113\u20131122","journal-title":"Brain"},{"key":"8213_CR49","first-page":"13","volume":"10","author":"Y Shoenfeld","year":"2008","unstructured":"Shoenfeld Y, Blank M, Abu-Shakra M, Amital H, Barzilai O, Berkun Y et al (2008) The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases\u20142008. Isr Med Assoc J 10:13\u201319","journal-title":"Isr Med Assoc J"},{"key":"8213_CR50","first-page":"3","volume":"10","author":"Y Shoenfeld","year":"2008","unstructured":"Shoenfeld Y, Gilburd B, Abu-Shakra M, Amital H, Barzilai O, Berkun Y et al (2008) The mosaic of autoimmunity: genetic factors involved in autoimmune diseases\u20142008. Isr Med Assoc J 10:3\u20137","journal-title":"Isr Med Assoc J"},{"key":"8213_CR51","first-page":"8","volume":"10","author":"Y Shoenfeld","year":"2008","unstructured":"Shoenfeld Y, Zandman-Goddard G, Stojanovich L, Cutolo M, Amital H, Levy Y et al (2008) The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases\u20142008. Isr Med Assoc J 10:8\u201312","journal-title":"Isr Med Assoc J"},{"key":"8213_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2007.11.015","volume":"30","author":"M Blank","year":"2008","unstructured":"Blank M, Gershwin ME (2008) Autoimmunity: from the mosaic to the kaleidoscope. J Autoimmun 30:1\u20134","journal-title":"J Autoimmun"},{"key":"8213_CR53","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jaut.2008.04.014","volume":"31","author":"IH Frazer","year":"2008","unstructured":"Frazer IH (2008) Autoimmunity and persistent viral infection: two sides of the same coin? J Autoimmun 31:216\u2013218","journal-title":"J Autoimmun"},{"key":"8213_CR54","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jaut.2008.09.002","volume":"31","author":"A Katzav","year":"2008","unstructured":"Katzav A, Ben-Ziv T, Chapman J, Blank M, Reichlin M, Shoenfeld Y (2008) Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS-SLE (depression). J Autoimmun 31:393\u2013398","journal-title":"J Autoimmun"},{"key":"8213_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2008.10.003","volume":"32","author":"OD Ortega-Hernandez","year":"2009","unstructured":"Ortega-Hernandez OD, Agmon-Levin N, Blank M, Asherson RA, Shoenfeld Y (2009) The physiopathology of the catastrophic antiphospholipid (Asherson's) syndrome: compelling evidence. J Autoimmun 32:1\u20136","journal-title":"J Autoimmun"},{"key":"8213_CR56","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jaut.2007.07.014","volume":"29","author":"KR Ryan","year":"2007","unstructured":"Ryan KR, Patel SD, Stephens LA, Anderton SM (2007) Death, adaptation and regulation: the three pillars of immune tolerance restrict the risk of autoimmune disease caused by molecular mimicry. J Autoimmun 29:262\u2013271","journal-title":"J Autoimmun"},{"key":"8213_CR57","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jaut.2008.08.004","volume":"31","author":"Y Shoenfeld","year":"2008","unstructured":"Shoenfeld Y, Selmi C, Zimlichman E, Gershwin ME (2008) The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J Autoimmun 31:325\u2013330","journal-title":"J Autoimmun"},{"key":"8213_CR58","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jaut.2007.10.002","volume":"30","author":"F Song","year":"2008","unstructured":"Song F, Wardrop RM, Gienapp IE, Stuckman SS, Meyer AL, Shawler T et al (2008) The Peyer's patch is a critical immunoregulatory site for mucosal tolerance in experimental autoimmune encephalomylelitis (EAE). J Autoimmun 30:230\u2013237","journal-title":"J Autoimmun"},{"key":"8213_CR59","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.autrev.2008.07.003","volume":"8","author":"A Ceribelli","year":"2008","unstructured":"Ceribelli A, Cavazzana I, Cattaneo R, Franceschini F (2008) Hepatitis C virus infection and primary Sjogren's syndrome: a clinical and serologic description of 9 patients. Autoimmun Rev 8:92\u201394","journal-title":"Autoimmun Rev"},{"key":"8213_CR60","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2008.07.007","volume":"8","author":"F Conti","year":"2008","unstructured":"Conti F, Rezai S, Valesini G (2008) Vaccination and autoimmune rheumatic diseases. Autoimmun Rev 8:124\u2013128","journal-title":"Autoimmun Rev"},{"key":"8213_CR61","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.autrev.2008.07.019","volume":"8","author":"A Doria","year":"2008","unstructured":"Doria A, Canova M, Tonon M, Zen M, Rampudda E, Bassi N et al (2008) Infections as triggers and complications of systemic lupus erythematosus. Autoimmun Rev 8:24\u201328","journal-title":"Autoimmun Rev"},{"key":"8213_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autrev.2008.07.014","volume":"8","author":"A Doria","year":"2008","unstructured":"Doria A, Sarzi-Puttini P, Shoenfeld Y (2008) Infections, rheumatism and autoimmunity: the conflicting relationship between humans and their environment. Autoimmun Rev 8:1\u20134","journal-title":"Autoimmun Rev"},{"key":"8213_CR63","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.autrev.2008.07.036","volume":"8","author":"A Doria","year":"2008","unstructured":"Doria A, Zampieri S, Sarzi-Puttini P (2008) Exploring the complex relationships between infections and autoimmunity. Autoimmun Rev 8:89\u201391","journal-title":"Autoimmun Rev"},{"key":"8213_CR64","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.autrev.2008.07.005","volume":"8","author":"C Lunardi","year":"2008","unstructured":"Lunardi C, Tinazzi E, Bason C, Dolcino M, Corrocher R, Puccetti A (2008) Human parvovirus B19 infection and autoimmunity. Autoimmun Rev 8:116\u2013120","journal-title":"Autoimmun Rev"},{"key":"8213_CR65","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.autrev.2008.07.026","volume":"8","author":"AL Nancy","year":"2008","unstructured":"Nancy AL, Shoenfeld Y (2008) Chronic fatigue syndrome with autoantibodies\u2014the result of an augmented adjuvant effect of hepatitis-B vaccine and silicone implant. Autoimmun Rev 8:52\u201355","journal-title":"Autoimmun Rev"},{"key":"8213_CR66","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.autrev.2006.09.001","volume":"6","author":"H Orbach","year":"2007","unstructured":"Orbach H, Shoenfeld Y (2007) Vaccination infection and autoimmunity: myth and reality VIAMR 2005-10-26-28, Beau-Rivage Palace Hotel, Lausanne, Switzerland. Autoimmun Rev 6:261\u2013266","journal-title":"Autoimmun Rev"},{"key":"8213_CR67","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.autrev.2008.10.001","volume":"8","author":"L Plot","year":"2009","unstructured":"Plot L, Amital H (2009) Infectious associations of Celiac disease. Autoimmun Rev 8:316\u2013319","journal-title":"Autoimmun Rev"},{"key":"8213_CR68","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.autrev.2008.12.008","volume":"8","author":"BD Poole","year":"2009","unstructured":"Poole BD, Templeton AK, Guthridge JM, Brown EJ, Harley JB, James JA (2009) Aberrant Epstein\u2013Barr viral infection in systemic lupus erythematosus. Autoimmun Rev 8:337\u2013342","journal-title":"Autoimmun Rev"},{"key":"8213_CR69","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.autrev.2008.04.012","volume":"7","author":"JF Seite","year":"2008","unstructured":"Seite JF, Shoenfeld Y, Youinou P, Hillion S (2008) What is the contents of the magic draft IVIg? Autoimmun Rev 7:435\u2013439","journal-title":"Autoimmun Rev"},{"key":"8213_CR70","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.autrev.2008.07.008","volume":"8","author":"N Toplak","year":"2008","unstructured":"Toplak N, Kveder T, Trampus-Bakija A, Subelj V, Cucnik S, Avcin T (2008) Autoimmune response following annual influenza vaccination in 92 apparently healthy adults. Autoimmun Rev 8:134\u2013138","journal-title":"Autoimmun Rev"},{"key":"8213_CR71","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.autrev.2008.07.013","volume":"8","author":"R Tozzoli","year":"2008","unstructured":"Tozzoli R, Barzilai O, Ram M, Villalta D, Bizzaro N, Sherer Y et al (2008) Infections and autoimmune thyroid diseases: parallel detection of antibodies against pathogens with proteomic technology. Autoimmun Rev 8:112\u2013115","journal-title":"Autoimmun Rev"},{"key":"8213_CR72","unstructured":"Global Advisory Committee on Vaccine Safety, 12\u201313 December 2007 (2008) Wkly Epidemiol Rec. 83, 37\u201344"},{"key":"8213_CR73","first-page":"767","volume":"22","author":"M Khamaisi","year":"2004","unstructured":"Khamaisi M, Shoenfeld Y, Orbach H (2004) Guillain\u2013Barre syndrome following hepatitis B vaccination. Clin Exp Rheumatol 22:767\u2013770","journal-title":"Clin Exp Rheumatol"},{"key":"8213_CR74","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1016\/j.vaccine.2008.07.014","volume":"26","author":"A Esteghamati","year":"2008","unstructured":"Esteghamati A, Gouya MM, Keshtkar AA, Mahoney F (2008) Relationship between occurrence of Guillain\u2013Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5\u201314\u00a0years old children. Vaccine 26:5058\u20135061","journal-title":"Vaccine"},{"key":"8213_CR75","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0002-9343(76)90762-2","volume":"60","author":"C Grose","year":"1976","unstructured":"Grose C, Spigland I (1976) Guillain\u2013Barre syndrome following administration of live measles vaccine. Am J Med 60:441\u2013443","journal-title":"Am J Med"},{"key":"8213_CR76","first-page":"1120","volume":"55","author":"Centers for Disease Control and Prevention (CDC)","year":"2006","unstructured":"Centers for Disease Control and Prevention (CDC) (2006) Update: Guillain\u2013Barre syndrome among recipients of Menactra meningococcal conjugate vaccine\u2014United States, June 2005\u2013September 2006. MMWR Morb Mortal Wkly Rep 55:1120\u20131124","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"8213_CR77","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1001\/jama.294.21.2744","volume":"294","author":"JJ Sejvar","year":"2005","unstructured":"Sejvar JJ, Labutta RJ, Chapman LE, Grabenstein JD, Iskander J, Lane JM (2005) Neurologic adverse events associated with smallpox vaccination in the United States, 2002\u20132004. Jama 294:2744\u20132750","journal-title":"Jama"},{"key":"8213_CR78","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/01.inf.0000130941.72712.33","volume":"23","author":"D Blumenthal","year":"2004","unstructured":"Blumenthal D, Prais D, Bron-Harlev E, Amir J (2004) Possible association of Guillain\u2013Barre syndrome and hepatitis A vaccination. Pediatr Infect Dis J 23:586\u2013588","journal-title":"Pediatr Infect Dis J"},{"key":"8213_CR79","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1590\/S0036-46651996000100010","volume":"38","author":"F Friedrich","year":"1996","unstructured":"Friedrich F, Filippis AM, Schatzmayr HG (1996) Temporal association between the isolation of Sabin-related poliovirus vaccine strains and the Guillain\u2013Barre syndrome. Rev Inst Med Trop S\u00e3o Paulo 38:55\u201358","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"key":"8213_CR80","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1067\/mpd.2001.111165","volume":"138","author":"A Patja","year":"2001","unstructured":"Patja A, Paunio M, Kinnunen E, Junttila O, Hovi T, Peltola H (2001) Risk of Guillain\u2013Barre syndrome after measles\u2013mumps\u2013rubella vaccination. J Pediatr 138:250\u2013254","journal-title":"J Pediatr"},{"key":"8213_CR81","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2105\/AJPH.87.12.2045","volume":"87","author":"J Tuttle","year":"1997","unstructured":"Tuttle J, Chen RT, Rantala H, Cherry JD, Rhodes PH, Hadler S (1997) The risk of Guillain\u2013Barre syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States. Am J Public Health 87:2045\u20132048","journal-title":"Am J Public Health"},{"key":"8213_CR82","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0022-510X(90)90127-9","volume":"96","author":"W Chaleomchan","year":"1990","unstructured":"Chaleomchan W, Hemachudha T, Sakulramrung R, Deesomchok U (1990) Anticardiolipin antibodies in patients with rabies vaccination induced neurological complications and other neurological diseases. J Neurol Sci 96:143\u2013151","journal-title":"J Neurol Sci"},{"key":"8213_CR83","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/inf.1980.12.issue-3.12","volume":"12","author":"E Boe","year":"1980","unstructured":"Boe E, Nyland H (1980) Guillain\u2013Barre syndrome after vaccination with human diploid cell rabies vaccine. Scand J Infect Dis 12:231\u2013232","journal-title":"Scand J Infect Dis"},{"key":"8213_CR84","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.1980.03300500016019","volume":"243","author":"JS Marks","year":"1980","unstructured":"Marks JS, Halpin TJ (1980) Guillain\u2013Barre syndrome in recipients of A\/New Jersey influenza vaccine. Jama 243:2490\u20132494","journal-title":"Jama."},{"key":"8213_CR85","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198106253042601","volume":"304","author":"ES Hurwitz","year":"1981","unstructured":"Hurwitz ES, Schonberger LB, Nelson DB, Holman RC (1981) Guillain\u2013Barre syndrome and the 1978\u20131979 influenza vaccine. N Engl J Med 304:1557\u20131561","journal-title":"N Engl J Med"},{"key":"8213_CR86","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1982.03330060038030","volume":"248","author":"JE Kaplan","year":"1982","unstructured":"Kaplan JE, Katona P, Hurwitz ES, Schonberger LB (1982) Guillain\u2013Barre syndrome in the United States, 1979\u20131980 and 1980\u20131981. Lack of an association with influenza vaccination. Jama 248:698\u2013700","journal-title":"Jama"},{"key":"8213_CR87","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S1521-6616(03)00046-9","volume":"107","author":"MR Geier","year":"2003","unstructured":"Geier MR, Geier DA, Zahalsky AC (2003) Influenza vaccination and Guillain\u2013Barre syndrome small star, filled. Clin Immunol 107:116\u2013121","journal-title":"Clin Immunol"},{"key":"8213_CR88","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1001\/jama.292.20.2478","volume":"292","author":"P Haber","year":"2004","unstructured":"Haber P, DeStefano F, Angulo FJ, Iskander J, Shadomy SV, Weintraub E et al (2004) Guillain\u2013Barre syndrome following influenza vaccination. Jama 292:2478\u20132481","journal-title":"Jama"},{"key":"8213_CR89","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/archinte.166.20.2217","volume":"166","author":"DN Juurlink","year":"2006","unstructured":"Juurlink DN, Stukel TA, Kwong J, Kopp A, McGeer A, Upshur RE et al (2006) Guillain\u2013Barre syndrome after influenza vaccination in adults: a population-based study. Arch Intern Med 166:2217\u20132221","journal-title":"Arch Intern Med"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-010-8213-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-010-8213-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-010-8213-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:48:48Z","timestamp":1559440128000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-010-8213-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,5]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["8213"],"URL":"https:\/\/doi.org\/10.1007\/s12016-010-8213-3","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,5]]}}}